Home About us Editorial board Ahead of print Current issue Search Archives Submit article Instructions Subscribe Contacts Login 
This article has been cited by
1A Rapid and Simple UHPLC-UV Method for Quantitative Determination of Erlotinib and Its Active Metabolite OSI-420 in Human Serum, and Its Application in a Non-Small Cell Lung Cancer Patient
Takahiro SUGA,Miki SHIMADA,Masamitsu MAEKAWA,Hiroyuki SUZUKI,Masaru MORI,Tatsuma OKAZAKI,Akira INOUE,Hiroaki YAMAGUCHI,Nariyasu MANO
CHROMATOGRAPHY.2017;38(3)95
[DOI]
2Erlotinib-Associated Interstitial Lung Disease in Advanced Pancreatic Carcinoma: A Case Report and Literature Review
Marianna Macerelli,Micol Mazzer,Luisa Foltran,Giovanni Gerardo Cardellino,Giuseppe Aprile
Tumori Journal.2015;101(4)e122
[DOI]
3Population Pharmacokinetics/Pharmacodynamics of Erlotinib and Pharmacogenomic Analysis of Plasma and Cerebrospinal Fluid Drug Concentrations in Japanese Patients with Non-Small Cell Lung Cancer
Masahide Fukudo,Yasuaki Ikemi,Yosuke Togashi,Katsuhiro Masago,Young Hak Kim,Tadashi Mio,Tomohiro Terada,Satoshi Teramukai,Michiaki Mishima,Ken-ichi Inui,Toshiya Katsura
Clinical Pharmacokinetics.2013;52(7)593
[DOI]
4Radiotherapy combined with gefitinib for patients with locally advanced non-small cell lung cancer who are unfit for surgery or concurrent chemoradiotherapy: a phase II clinical trial
Zhixue Fu,Xu Yang,Wenqing Wang,Lei Deng,Tao Zhang,Nan Bi,Xiaozhen Wang,Dongfu Chen,Zongmei Zhou,Luhua Wang,Jun Liang
Radiation Oncology.2020;15(1)593
[DOI]
5Re-evaluation of cytostatic therapies for meningiomas in vitro
Annette Wilisch-Neumann,Doreen Pachow,Maren Wallesch,Astrid Petermann,Frank D. Böhmer,Elmar Kirches,Christian Mawrin
Journal of Cancer Research and Clinical Oncology.2014;140(8)1343
[DOI]
6Targeting the Trafficking of Kidney Water Channels for Therapeutic Benefit
Pui W. Cheung,Richard Bouley,Dennis Brown
Annual Review of Pharmacology and Toxicology.2020;60(1)175
[DOI]
7Radiation Pneumonitis in Patients with Non–Small-Cell Lung Cancer Treated with Erlotinib Concurrent with Thoracic Radiotherapy
Hongqing Zhuang,Zhiyong Yuan,Joe Y. Chang,Jun Wang,Qingsong Pang,Lujun Zhao,Ping Wang
Journal of Thoracic Oncology.2014;9(6)882
[DOI]
8Population pharmacokinetics of erlotinib in Japanese patients with advanced non-small cell lung cancer
Y. Emoto-Yamamoto,S. Iida,T. Kawanishi,M. Fukuoka
Journal of Clinical Pharmacy and Therapeutics.2015;40(2)232
[DOI]
9Erlotinib: Lacking of Cholinergic Effects on Tracheal Smooth Muscle
Chih-Cheng Chang,Hsiao-Chi Chuang,Chun-Nin Lee,Wen-Yueh Hung,Hsing-Won Wang
Journal of Experimental & Clinical Medicine.2014;6(3)98
[DOI]
10Gefitinib exposure and occurrence of interstitial lung disease in Japanese patients with non-small-cell lung cancer
Toshio Kawata,Mitsuo Higashimori,Yohji Itoh,Helen Tomkinson,Martin G. Johnson,Weifeng Tang,Fredrik Nyberg,Haiyi Jiang,Yusuke Tanigawara
Cancer Chemotherapy and Pharmacology.2019;83(5)849
[DOI]

Subscribe this journal
Submit articles
Most popular articles
Joiu us as a reviewer
Email alerts
Recommend this journal